CFS Central
Beyond-the-headlines reporting on
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Thursday, June 6, 2013
Ampligen Up for Approval--
in Argentina
›
Hemispherx, the company that makes the experimental ME drug Ampligen, applied for approval in Argentina in July of 2012. ANMAT (Administr...
3 comments:
Wednesday, April 24, 2013
GONE TO THE FDA
›
I'm going to the FDA tomorrow and Friday. If Internet connections and my Kindle cooperate, I'll try to post on Twitter in real o...
3 comments:
Monday, February 4, 2013
Ampligen: It's a NO
›
From the GlobeNewswire: Hemispherx Biopharma, Inc. (NYSE MKT: HEB ) (the "Company" or "Hemispherx"), announced t...
1 comment:
Sunday, February 3, 2013
Hamlet Without Hamlet
›
Patient advocate Bob Miller, who's on the experimental drug Ampligen, has been urging FDA to approve the medication for ME by going on...
2 comments:
‹
›
Home
View web version